scholarly journals Reactance to Social Authority in a Sugar Reduction Informational Video: Web-Based Randomized Controlled Trial of 4013 Participants

10.2196/29664 ◽  
2021 ◽  
Vol 23 (11) ◽  
pp. e29664
Author(s):  
Violetta Hachaturyan ◽  
Maya Adam ◽  
Caterina Favaretti ◽  
Merlin Greuel ◽  
Jennifer Gates ◽  
...  

Background Short and animated story-based (SAS) videos can be an effective strategy for promoting health messages. However, health promotion strategies often motivate the rejection of health messages, a phenomenon known as reactance. In this study, we examine whether the child narrator of a SAS video (perceived as nonthreatening, with low social authority) minimizes reactance to a health message about the consumption of added sugars. Objective This study aims to determine whether our SAS intervention video attenuates reactance to the sugar message when compared with a content placebo video (a health message about sunscreen) and a placebo video (a nonhealth message about earthquakes) and determine if the child narrator is more effective at reducing reactance to the sugar message when compared with the mother narrator (equivalent social authority to target audience) or family physician narrator (high social authority) of the same SAS video. Methods This is a web-based randomized controlled trial comparing an intervention video about sugar reduction narrated by a child, the child’s mother, or the family physician with a content placebo video about sunscreen use and a placebo video about earthquakes. The primary end points are differences in the antecedents to reactance (proneness to reactance, threat level of the message), its components (anger and negative cognition), and outcomes (source appraisal and attitude). We performed analysis of variance on data collected (N=4013) from participants aged 18 to 59 years who speak English and reside in the United Kingdom. Results Between December 9 and December 11, 2020, we recruited 38.62% (1550/4013) men, 60.85% (2442/4013) women, and 0.52% (21/4013) others for our study. We found a strong causal relationship between the persuasiveness of the content promoted by the videos and the components of reactance. Compared with the placebo (mean 1.56, SD 0.63) and content placebo (mean 1.76, SD 0.69) videos, the intervention videos (mean 1.99, SD 0.83) aroused higher levels of reactance to the message content (P<.001). We found no evidence that the child narrator (mean 1.99, SD 0.87) attenuated reactance to the sugar reduction message when compared with the physician (mean 1.95, SD 0.79; P=.77) and mother (mean 2.03, SD 0.83; P=.93). In addition, the physician was perceived as more qualified, reliable, and having more expertise than the child (P<.001) and mother (P<.001) narrators. Conclusions Although children may be perceived as nonthreatening messengers, we found no evidence that a child narrator attenuated reactance to a SAS video about sugar consumption when compared with a physician. Furthermore, our intervention videos, with well-intended goals toward audience health awareness, aroused higher levels of reactance when compared with the placebo videos. Our results highlight the challenges in developing effective interventions to promote persuasive health messages. Trial Registration German Clinical Trials Registry DRKS00022340; https://tinyurl.com/mr8dfena International Registered Report Identifier (IRRID) RR2-10.2196/25343

2021 ◽  
Author(s):  
Violetta Hachaturyan ◽  
Maya Adam ◽  
Caterina Favaretti ◽  
Merlin Greuel ◽  
Jennifer Gates ◽  
...  

BACKGROUND Short and animated story-based (SAS) videos can be an effective strategy for promoting health messages. However, health promotion strategies often motivate the rejection of health messages, a phenomenon known as reactance. In this study, we examine whether the child narrator of a SAS video (perceived as nonthreatening, with low social authority) minimizes reactance to a health message about the consumption of added sugars. OBJECTIVE This study aims to determine whether our SAS intervention video attenuates reactance to the sugar message when compared with a content placebo video (a health message about sunscreen) and a placebo video (a nonhealth message about earthquakes) and determine if the child narrator is more effective at reducing reactance to the sugar message when compared with the mother narrator (equivalent social authority to target audience) or family physician narrator (high social authority) of the same SAS video. METHODS This is a web-based randomized controlled trial comparing an intervention video about sugar reduction narrated by a child, the child’s mother, or the family physician with a content placebo video about sunscreen use and a placebo video about earthquakes. The primary end points are differences in the antecedents to reactance (proneness to reactance, threat level of the message), its components (anger and negative cognition), and outcomes (source appraisal and attitude). We performed analysis of variance on data collected (N=4013) from participants aged 18 to 59 years who speak English and reside in the United Kingdom. RESULTS Between December 9 and December 11, 2020, we recruited 38.62% (1550/4013) men, 60.85% (2442/4013) women, and 0.52% (21/4013) others for our study. We found a strong causal relationship between the persuasiveness of the content promoted by the videos and the components of reactance. Compared with the placebo (mean 1.56, SD 0.63) and content placebo (mean 1.76, SD 0.69) videos, the intervention videos (mean 1.99, SD 0.83) aroused higher levels of reactance to the message content (<i>P</i>&lt;.001). We found no evidence that the child narrator (mean 1.99, SD 0.87) attenuated reactance to the sugar reduction message when compared with the physician (mean 1.95, SD 0.79; <i>P</i>=.77) and mother (mean 2.03, SD 0.83; <i>P</i>=.93). In addition, the physician was perceived as more qualified, reliable, and having more expertise than the child (<i>P&lt;</i>.001) and mother (<i>P&lt;</i>.001) narrators. CONCLUSIONS Although children may be perceived as nonthreatening messengers, we found no evidence that a child narrator attenuated reactance to a SAS video about sugar consumption when compared with a physician. Furthermore, our intervention videos, with well-intended goals toward audience health awareness, aroused higher levels of reactance when compared with the placebo videos. Our results highlight the challenges in developing effective interventions to promote persuasive health messages. CLINICALTRIAL German Clinical Trials Registry DRKS00022340; https://tinyurl.com/mr8dfena INTERNATIONAL REGISTERED REPORT RR2-10.2196/25343


2020 ◽  
Author(s):  
Alain Vandormael ◽  
Maya Adam ◽  
Merlin Greuel ◽  
Violetta Hachaturyan ◽  
Caterina Favaretti ◽  
...  

BACKGROUND Entertainment-education (E-E) media can be an effective strategy for influencing health behaviors. To improve E-E effectiveness, we investigate if the social authority of a person delivering a health message arouses motivation to reject that message—a phenomenon known as reactance. Using a short, animated video, we measure reactance to a sugar reduction message that is narrated by a child (low social authority), the child’s mother (equivalent social authority to the target audience), and the family physician (high social authority). OBJECTIVE This study aims to 1) determine the effect of the narrator’s social authority on reactance to the sugar reduction message; 2) establish the video’s effectiveness in improving behavioral intent to reduce the intake of added sugars; and 3) quantify participant’s interest in watching the E-E intervention video. METHODS This is a parallel group, randomized controlled trial comparing an intervention video narrated by a (i) low, (ii) equivalent, or (iii) high social authority against an (iv) attention placebo control video, and a (v) control video. The primary outcomes will include measures of antecedents of reactance, its components, and its attitudinal and behavioral outcomes. For our secondary outcome, we will assess participant engagement with the sugar intervention videos. We will leverage a regression framework to analyze online data collected from 4,000 English-speaking participants aged 18 to 59 years. RESULTS The study received ethics approval from the Heidelberg University’s Ethics Committee on March 18th, 2020 (S-088/2020). The participant recruitment has not started yet but is planned to be completed by December 2020. The data analysis is planned to be finished in February 2021 and the final results are planned to be published by April 2021. CONCLUSIONS This trial will utilize several randomization procedures, list experimentation methods, and new online technologies to investigate the effect of social authority on reactance to a persuasive health message. Our results will inform the design of future E-E videos for public health promotion needs. CLINICALTRIAL This study was registered at the German Clinical Trials Register (www.drks.de) on July 24th, 2020: DRKS00022340.


2019 ◽  
Author(s):  
Jan van Lieshout ◽  
Joyca Lacroix ◽  
Aart van Halteren ◽  
Martina Teichert

BACKGROUND Growing numbers of people use medication for chronic conditions; non-adherence is common, leading to poor disease control. A newly developed web-based tool to identify an increased risk for non-adherence with related potential individual barriers might facilitate tailored interventions and improve adherence. OBJECTIVE To assess the effectiveness of the newly developed tool to improve medication adherence. METHODS A cluster randomized controlled trial assessed the effectiveness of this adherence tool in patients initiating cardiovascular or oral blood glucose lowering medication. Participants were included in community pharmacies. They completed an online questionnaire comprising an assessments of their risk for medication non-adherence and subsequently of barriers to adherence. In pharmacies belonging to the intervention group, individual barriers displayed in a graphical profile on a tablet were discussed by pharmacists and patients at high non-adherence risk in face to face meetings and shared with their general practitioners and practice nurses. Tailored interventions were initiated by the healthcare providers. Barriers of control patients were not presented or discussed and these patients received usual care. The primary outcome was the difference in medication adherence at 8 months follow-up between patients with an increased non-adherence risk from intervention and control group, calculated from dispensing data. RESULTS Data from 492 participants in 15 community pharmacies were available for analyses (intervention 253, 7 pharmacies; control 239, 8 pharmacies). The intervention had no effect on medication adherence (-0.01; 95%CI -0.59 – 0.57; P= .96), neither in the post hoc per protocol analysis (0.19; 95%CI -0.50 – 0.89; P=.58). CONCLUSIONS This study showed no effectiveness of a risk stratification and tailored intervention addressing personal barriers for medication adherence. Various potential explanations for lack of effect were identified. These explanations relate for instance to high medication adherence in the control group, study power and fidelity. Process evaluation should elicit possible improvements and inform the redesign of intervention and implementation. CLINICALTRIAL The Netherlands National Trial Register: NTR5186. Date: May 18, 2015 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5186)


2021 ◽  
Author(s):  
Erin K. Tagai ◽  
Suzanne M. Miller ◽  
Shawna V. Hudson ◽  
Michael A. Diefenbach ◽  
Elizabeth Handorf ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document